RE:RE:RE:RE:RE:Q2I hope you're right. We'll see what happens tomorrow with the share price. I just felt this press release was preaching to the choir. Us longs know this company is undervalued and have great potential. But new investors to this name will want to know more concretely whether we should expect similar growth in the future and how the pandemic is affecting the bottom line. I just felt this press release did not generate the same level of excitement I got when reading the Viemed press release.